Monotherapy Versus Combination Therapy Beyond 12 Months After Coronary Intervention in Older Atrial Fibrillation Patients.
BACKGROUND Atrial fibrillation with coronary artery disease poses therapeutic challenges. Although guidelines recommend de-escalating to oral anticoagulant agent monotherapy >12 months after percutaneous coronary intervention (PCI), real-world data on major adverse cardiovascular events (MACE) and major bleeding in old...